Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jun 12 02:43PM ET
3.53
Dollar change
+0.22
Percentage change
6.65
%
IndexRUT P/E- EPS (ttm)-3.37 Insider Own54.98% Shs Outstand43.22M Perf Week20.07%
Market Cap152.56M Forward P/E- EPS next Y-3.15 Insider Trans0.00% Shs Float19.45M Perf Month52.16%
Income-145.42M PEG- EPS next Q-1.04 Inst Own25.51% Short Float10.75% Perf Quarter41.20%
Sales0.00M P/S- EPS this Y-11.70% Inst Trans-15.72% Short Ratio6.26 Perf Half Y-27.37%
Book/sh5.18 P/B0.68 EPS next Y15.42% ROA-44.70% Short Interest2.09M Perf Year-73.89%
Cash/sh5.61 P/C0.63 EPS next 5Y-2.34% ROE-49.72% 52W Range1.78 - 16.64 Perf YTD-5.61%
Dividend Est.- P/FCF- EPS past 5Y- ROIC-63.96% 52W High-78.79% Beta2.71
Dividend TTM- Quick Ratio7.44 Sales past 5Y- Gross Margin- 52W Low98.31% ATR (14)0.30
Dividend Ex-Date- Current Ratio7.44 EPS Y/Y TTM-48.62% Oper. Margin- RSI (14)68.98 Volatility9.30% 7.82%
Employees112 Debt/Eq0.03 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price17.20
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q8.09% Payout- Rel Volume1.17 Prev Close3.31
Sales Surprise- EPS Surprise8.50% Sales Q/Q- EarningsMay 13 AMC Avg Volume334.22K Price3.53
SMA2029.00% SMA5051.08% SMA200-8.77% Trades Volume317,095 Change6.65%
Date Action Analyst Rating Change Price Target Change
May-27-25Upgrade H.C. Wainwright Neutral → Buy $5
Oct-10-24Initiated UBS Buy $13
Oct-09-24Initiated Rodman & Renshaw Buy $16
Jul-03-24Initiated H.C. Wainwright Neutral $8
Mar-04-24Initiated Wells Fargo Overweight $44
Mar-04-24Initiated Morgan Stanley Overweight $40
Mar-04-24Initiated Leerink Partners Outperform $48
Mar-04-24Initiated JP Morgan Overweight $39
May-28-25 04:02PM
May-16-25 06:36AM
May-13-25 04:02PM
Apr-17-25 07:38AM
Mar-27-25 04:02PM
09:13AM Loading…
Mar-24-25 09:13AM
Mar-21-25 11:29AM
08:32AM
Mar-18-25 04:48PM
Mar-17-25 03:01PM
Mar-03-25 04:05PM
Feb-10-25 12:00PM
Jan-21-25 04:05PM
Jan-17-25 05:45AM
Jan-13-25 07:30AM
08:00AM Loading…
Jan-08-25 08:00AM
Jan-07-25 05:45AM
Jan-06-25 04:05PM
Dec-27-24 05:45AM
Dec-19-24 12:16PM
Dec-13-24 04:05PM
Dec-09-24 06:38PM
Nov-14-24 10:01AM
Nov-13-24 04:14PM
Oct-21-24 08:00AM
Oct-19-24 11:13AM
Oct-10-24 03:05PM
Sep-18-24 08:00AM
Sep-16-24 08:00AM
06:58AM
04:05PM Loading…
Aug-21-24 04:05PM
Aug-12-24 04:08PM
04:05PM
Jul-16-24 11:33AM
08:52AM
Jul-15-24 04:05PM
Jun-20-24 08:55AM
Jun-17-24 04:05PM
Jun-10-24 04:05PM
Jun-07-24 08:55AM
May-14-24 10:54PM
04:05PM
Apr-11-24 05:01PM
Mar-29-24 02:59PM
Mar-26-24 04:05PM
Mar-14-24 07:00AM
Mar-07-24 07:26PM
06:14PM
Feb-12-24 04:39PM
Feb-07-24 10:29PM
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.